Compare CDIO & HUBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CDIO | HUBC |
|---|---|---|
| Founded | 2017 | 2017 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3M | 25.0M |
| IPO Year | N/A | N/A |
| Metric | CDIO | HUBC |
|---|---|---|
| Price | $3.51 | $0.53 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 30.3K | ★ 2.1M |
| Earning Date | 11-12-2025 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $15,782.00 | ★ $29,562,000.00 |
| Revenue This Year | $1,434.82 | N/A |
| Revenue Next Year | $4,661.91 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.42 | $0.36 |
| 52 Week High | $53.10 | $14.00 |
| Indicator | CDIO | HUBC |
|---|---|---|
| Relative Strength Index (RSI) | 52.40 | 19.94 |
| Support Level | $2.85 | $0.36 |
| Resistance Level | $3.91 | $1.08 |
| Average True Range (ATR) | 0.39 | 0.16 |
| MACD | 0.12 | -0.04 |
| Stochastic Oscillator | 56.82 | 19.42 |
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.
Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.